Lawson-Michod KA, Johnson CE, Barnard ME, Davidson NR, Collin LJ, Nix DA, Huff CD, Berchuck A, Salas LA, Greene CS, Marks JR, Peres LC, Doherty JA, Schildkraut JM. Homologous recombination deficiency and survival in ovarian high-grade serous carcinoma by self-reported race. Cancer Epidemiol Biomarkers Prev. 2025 Sep 4. [Epub ahead of print] PubMed PMID: 40905821
Johnson CE, Ran X, Wrobel J, Davidson NR, Greene CS, Epstein MP, Marks JR, Peres LC, Doherty JA, Schildkraut JM. An Analytic Pipeline to Obtain Reliable Genetic Ancestry Estimates from Tumor-Derived RNA Sequencing Data. Cancer Epidemiol Biomarkers Prev. 2025 Sep 2;34(9):1593-1599. PubMed PMID: 40622249
Ivich A, Davidson NR, Grieshober L, Li W, Hicks SC, Doherty JA, Greene CS. Missing cell types in single-cell references impact deconvolution of bulk data but are detectable. Genome Biol. 2025 Apr 7;26(1):86. PubMed PMID: 40197327
Lawson-Michod KA, Marks JR, Collin LJ, Nix DA, Davidson NR, Huff CD, Yu Y, Atkinson A, Johnson CE, Salas LA, Peres LC, Greene CS, Schildkraut JM, Doherty JA. Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals. Cancer Res. 2025 May 2;85(9):1725-1737. PubMed PMID: 40063699
Davidson NR, Zhang F, Greene CS. BuDDI: Bulk Deconvolution with Domain Invariance to predict cell-type-specific perturbations from bulk. PLoS Comput Biol. 2025 Jan;21(1):e1012742. PubMed PMID: 39823522
Lin S, Nguyen LL, McMellen A, Leibowitz MS, Davidson N, Spinosa D, Bitler BG. Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer. Molecular Diagnosis & Therapy. 2024 Nov 18:1-7.
